SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

RBC Raises PTC Therapeutics Price Target to $77 From $75

RBC Capital Markets maintained its Sector Perform rating on PTC Therapeutics. The target change follows the company's third-quarter 2026 results and updated full-year revenue guidance.

PTCT

Related stories